5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.06▼ | 8.11▼ | 8.14▼ | 8.26▼ | 8.86▼ |
MA10 | 8.12▼ | 8.10▼ | 8.08▼ | 8.34▼ | 8.66▼ |
MA20 | 8.13▼ | 8.26▼ | 8.35▼ | 8.72▼ | 6.25▲ |
MA50 | 8.30▼ | 8.60▼ | 8.89▼ | 8.33▼ | 11.48▼ |
MA100 | 8.84▼ | 9.38▼ | 8.58▼ | 6.04▲ | 16.38▼ |
MA200 | 9.37▼ | 8.79▼ | 7.62▲ | 9.91▼ | 97.19▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.018▼ | 0.003▲ | 0.011▲ | -0.142▼ | 0.672▲ |
RSI | 42.146▼ | 40.853▼ | 40.343▼ | 44.847▼ | 49.665▼ |
STOCH | 27.843 | 54.879 | 53.486 | 50.411 | 56.917 |
WILL %R | -83.846▼ | -83.846▼ | -86.093▼ | -60.063 | -50.067 |
CCI | -99.171 | -84.246 | -95.083 | -109.346▼ | 27.288 |
Friday, August 01, 2025 06:00 AM
SYDNEY, Aug. 1, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase ...
|
Friday, August 01, 2025 05:08 AM
Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase agreement with certain established institutional ...
|
Wednesday, July 09, 2025 07:46 AM
$82.67 0.05 % Kazia Therapeutics KZIA on Wednesday reported preliminary results from the first patient in its Phase 1b trial evaluating a combination regimen of Paxalisib, Merck & Co Inc’s MRK ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 7.8838 | 8.19 | 7.80 | 8.035 | 10,312 |
14/08/25 | 8.02 | 8.33 | 8.0101 | 8.27 | 6,400 |
13/08/25 | 8.29 | 8.876 | 8.28 | 8.3275 | 10,627 |
12/08/25 | 7.98 | 8.52 | 7.80 | 8.50 | 16,813 |
11/08/25 | 8.07 | 8.30 | 7.5796 | 8.17 | 24,877 |
08/08/25 | 8.17 | 8.46 | 7.86 | 8.12 | 9,904 |
07/08/25 | 8.7398 | 8.7398 | 8.24 | 8.24 | 12,823 |
06/08/25 | 8.82 | 8.99 | 8.4177 | 8.67 | 23,094 |
05/08/25 | 8.475 | 8.68 | 8.2055 | 8.68 | 10,644 |
04/08/25 | 7.90 | 8.66 | 7.8527 | 8.34 | 26,168 |
|
|
||||
|
|
||||
|
|